Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers-Reference-Cited by-同舟云学术

Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers

Published:2022-10-13 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Tang Yao¹,Zhou Cong¹,Li Qingli¹,Cheng Xiaojiao¹,Huang Tinglei¹,Li Fuli¹,He Lina¹,Zhang Baiweng¹,Tu Shuiping¹

Affiliation:

1. State Key Laboratory of Oncogenesis and Related Genes, Department of Oncology, Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China

Funder

Chinese Society of Clinical Oncology

National Natural Science Foundation of China

Shanghai Science and Technology Committee

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2131084

Reference49 articles.

1. Cancer immunotherapy: Current applications and challenges

2. Cancer immunotherapy using checkpoint blockade

3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

4. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

5. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells;Heliyon;2024-08

2. The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research;Frontiers in Immunology;2024-07-19

3. Trial watch: local anesthetics in cancer therapy;OncoImmunology;2024-03-17

4. Trial watch: dexmedetomidine in cancer therapy;OncoImmunology;2024-03-11

5. Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells;Cell Cycle;2024-03-03